RadNet, Inc. (RDNT)
78.22
+2.73
(+3.62%)
USD |
NASDAQ |
Sep 15, 10:54
RadNet Enterprise Value : 7.693B for Sept. 14, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 14, 2026 | 7.693B |
| September 11, 2026 | 7.693B |
| September 10, 2026 | 7.598B |
| September 09, 2026 | 7.329B |
| September 08, 2026 | 7.416B |
| September 04, 2026 | 7.553B |
| September 03, 2026 | 7.624B |
| September 02, 2026 | 7.709B |
| September 01, 2026 | 7.695B |
| August 31, 2026 | 7.719B |
| August 28, 2026 | 7.624B |
| August 27, 2026 | 7.683B |
| August 26, 2026 | 7.770B |
| August 25, 2026 | 7.801B |
| August 24, 2026 | 7.630B |
| August 21, 2026 | 7.797B |
| August 20, 2026 | 7.815B |
| August 19, 2026 | 7.697B |
| August 18, 2026 | 7.562B |
| August 17, 2026 | 7.727B |
| August 14, 2026 | 7.760B |
| August 13, 2026 | 7.836B |
| August 12, 2026 | 7.808B |
| August 11, 2026 | 7.760B |
| August 10, 2026 | 7.834B |
| Date | Value |
|---|---|
| August 07, 2026 | 7.449B |
| August 06, 2026 | 7.116B |
| August 05, 2026 | 7.030B |
| August 04, 2026 | 7.200B |
| August 03, 2026 | 7.009B |
| July 31, 2026 | 6.772B |
| July 30, 2026 | 6.686B |
| July 29, 2026 | 6.740B |
| July 28, 2026 | 6.728B |
| July 27, 2026 | 6.593B |
| July 24, 2026 | 6.598B |
| July 23, 2026 | 6.552B |
| July 22, 2026 | 6.413B |
| July 21, 2026 | 6.622B |
| July 20, 2026 | 6.528B |
| July 17, 2026 | 6.647B |
| July 16, 2026 | 6.710B |
| July 15, 2026 | 6.585B |
| July 14, 2026 | 6.693B |
| July 13, 2026 | 6.735B |
| July 10, 2026 | 6.915B |
| July 09, 2026 | 6.942B |
| July 08, 2026 | 6.914B |
| July 07, 2026 | 7.090B |
| July 06, 2026 | 7.176B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Castle Biosciences, Inc. | 790.05M |
| Lumexa Imaging Holdings, Inc. | 2.000B |
| Quest Diagnostics, Inc. | 32.31B |
| Labcorp Holdings, Inc. | 32.15B |
| OPKO Health, Inc. | 1.261B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 20.25M |
| Revenue (Quarterly) | 622.72M |
| Total Expenses (Quarterly) | 615.19M |
| EPS Diluted (Quarterly) | 0.0956 |
| Gross Profit Margin (Quarterly) | 7.89% |
| Profit Margin (Quarterly) | 3.25% |
| Earnings Yield | -0.35% |
| Operating Earnings Yield | 1.73% |
| Normalized Earnings Yield | -0.0177 |